Related Experiment Videos
Decrease in activity of smooth muscle L-type Ca2+ channels and its reversal by NF-kappaB inhibitors in Crohn's
Kazuya Kinoshita1, Koichi Sato, Masatoshi Hori
1Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan.
Summary
Crohn's disease impairs colonic muscle contractions by reducing L-type calcium channel activity, potentially via NF-kappaB pathways. This finding offers insights into gut dysmotility mechanisms in inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Physiology
- Molecular Biology
Background:
- Crohn's disease is associated with gastrointestinal dysmotility.
- The precise mechanisms underlying colonic smooth muscle dysfunction in Crohn's disease remain unclear.
Purpose of the Study:
- To investigate the mechanisms of colonic circular muscle dysmotility in a rat model of Crohn's disease.
- To identify the role of L-type calcium channels and NF-kappaB signaling in TNBS-induced colitis.
Main Methods:
- Induction of colitis using 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats.
- Assessment of colonic circular muscle contractility and L-type calcium channel activity.
- Analysis of L-type calcium channel mRNA and protein expression.
- Evaluation of NF-kappaB inhibitors' effects on contractility and channel activity.
Main Results:
- TNBS-induced colitis significantly decreased contractility in response to KCl, carbachol, and Bay K 8644.
- L-type calcium channel current density was reduced in TNBS-treated colonic smooth muscle cells, without changes in mRNA or protein expression.
- NF-kappaB inhibitors partially restored contractility and L-type calcium channel current density.
Conclusions:
- Decreased L-type calcium channel activity, not altered protein levels, underlies reduced colonic smooth muscle contraction in TNBS-induced colitis.
- NF-kappaB-dependent pathways likely mediate the dysfunction of L-type calcium channels, contributing to gut dysmotility in Crohn's disease models.